| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/26/2001 | US6251903 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonist |
| 06/26/2001 | US6251902 Dipeptide derivatives as growth hormone secretagogues |
| 06/26/2001 | US6251901 Compositions and methods for treating bone deficit conditions |
| 06/26/2001 | US6251896 Compositions and methods for the management of Crohn's disease |
| 06/26/2001 | US6251895 Stable crystalline dihydrate d olanzapine polymorph |
| 06/26/2001 | US6251894 1-(1,2-disubstituted piperidinyl)-4 (fused imidazole)-piperidine derivatives |
| 06/26/2001 | US6251893 Bicyclic piperidine and piperazine compounds having 5-HT6 receptor affinity |
| 06/26/2001 | US6251892 Neurotrophic low molecular weight small molecule n-oxides of heterocyclic esters, amides, thioesters and ketones; inhibitors of enzyme activity associated with immunophilin proteins, particularly peptidyl-prolyl isomerase or rotamase |
| 06/26/2001 | US6251890 Treating or preventing bacterial infections in mammalian patients |
| 06/26/2001 | US6251889 Orally administering composition comprising chromic tripicolinate in combination with picolinic acid to individual to facilitate absorption of one or more essential metals |
| 06/26/2001 | US6251888 Chromium picolinate compositions and uses thereof |
| 06/26/2001 | US6251887 17β-aryl(arylmethyl)oxy(thio)alkyl-androstane derivatives |
| 06/26/2001 | US6251886 Methods of using temozolomide in the treatment of cancers |
| 06/26/2001 | US6251885 Treating microorganism infection, lung cancer, breast cancer or leukemia in mammal |
| 06/26/2001 | US6251884 Pharmacologically acceptable composition for inhibiting or treating liver disease or inflammatory condition of gastrointestinal tract in mammal, comprising sulfate of ursodeoxycholic acid or salt thereof, carrier |
| 06/26/2001 | US6251883 Methods for preparation and use of 1α,24(S)-dihydroxy vitamin D2 |
| 06/26/2001 | US6251881 Method of treating diabetic angiopathy |
| 06/26/2001 | US6251879 Reducing wool fiber diameter in wool producing animal by administering effective amount of antimethanogenic agent for time and under conditions sufficient to allow wool growth |
| 06/26/2001 | US6251878 Inhibition of UV-induced immune suppression and interleukin-10 production by cytoprotective tamarind oligosaccharides |
| 06/26/2001 | US6251877 Topically administering to individual composition comprising purified beta-1,6-branched-beta-1,3-glucan from schizophyllum commune in amount effective to cause proliferation of skin cells |
| 06/26/2001 | US6251876 Autocross-linked hyaluronic acid and related pharmaceutical compositions for the treatment of arthropathies |
| 06/26/2001 | US6251875 Treating constipation |
| 06/26/2001 | US6251870 Pharmaceutical composition for inhibiting growth of cancers |
| 06/26/2001 | US6251869 Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives |
| 06/26/2001 | US6251865 Insulin-like growth factor agonist molecules |
| 06/26/2001 | US6251858 Derivatives of glycosylamine in which the oligosides are fixed on at least one molecule, matrix or particle |
| 06/26/2001 | US6251854 N-methyl-d-aspartate receptor channel blockers and method for identifying such |
| 06/26/2001 | US6251853 Pertussis toxin (ptx); beta-3 subunit of human g protein with not more than six wd repeat motifs; for the diagnosis of disorders, such as a disease associated with g protein dysregulation (i.e. hypertension) |
| 06/26/2001 | US6251682 Method and markers for prognosticating efficacy of anticancer agents |
| 06/26/2001 | US6251652 Amino acid sequence from staphylococcus cystathionine gamma-lyase gene; drug screening; bactericides; bacteriostats; vaccines; antibodies |
| 06/26/2001 | US6251647 Nucleotide and amino acid sequences; drug screening of bactericides for staphylococcus infections |
| 06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
| 06/26/2001 | US6251628 Isolated nucleic acid molecules encoding Smad7 |
| 06/26/2001 | US6251617 Screening for modulators of glycine transport; incubate cells with modulator and measure amount of glycine transport activity |
| 06/26/2001 | US6251580 Platelet storage nutrient solution; for use in the purification of platelets |
| 06/26/2001 | US6251442 Feed composition for broilers and method for breeding broilers |
| 06/26/2001 | US6251439 Composition and method for reducing the risk of carcinogenesis |
| 06/26/2001 | US6251438 Method of preparing active substances from nacre, products obtained which can be used in particular as medicaments |
| 06/26/2001 | US6251436 Drug preparations for treating sexual dysfunction |
| 06/26/2001 | US6251434 Preparations of non-steroidal analgesics |
| 06/26/2001 | US6251433 Polycationic polymers |
| 06/26/2001 | US6251429 Programmed release ambroxol—HCl dosage forms |
| 06/26/2001 | US6251428 Preparation of aqueous clear solution dosage forms with bile acids |
| 06/26/2001 | US6251427 Pharmaceutical capsule compositions containing loratadine and psuedoephedrine |
| 06/26/2001 | US6251426 Ibuprofen-containing softgels |
| 06/26/2001 | US6251420 Isoflavanoid formulations for oral administration |
| 06/26/2001 | US6251418 Delivering and implanting pellets containing a drug into the myocardial tissue; treating restenosis |
| 06/26/2001 | US6251405 Comprising borrelia burgdorferi outer surface protein (osp)c antigen and a second antigenic lipoprotein such as recombinant ospa, or streptococcus pneumoniae cell surface protein (pspa), both in same physio-chemical form |
| 06/26/2001 | US6251400 Comprising limonin and/or nomilin, and a tocotrienol |
| 06/26/2001 | US6251394 Method and a system for enhanced in vivo clearance of diagnostic and/or therapeutic agents by extracorporeal depletion, and the use of said agents for said purpose |
| 06/26/2001 | US6251392 Polypeptides for cell targets |
| 06/26/2001 | US6251371 Treatment of skin or mucosa inflammation by topical treatment with preparation containing dichlorobenzyl alcohol |
| 06/26/2001 | US6251368 Aerosol drugs salmeterol, salbutamol, fluticasone propionate, beclomethasone dipropionate and physiologically acceptable salts |
| 06/26/2001 | US6251355 Fine cisplatin powder and process for the production thereof |
| 06/26/2001 | US6250300 System for dispensing pharmaceutically active compounds |
| 06/26/2001 | CA2278133C Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid |
| 06/26/2001 | CA2245461C Detection of conditions or diseases associated with an altered level of telomerase activity |
| 06/26/2001 | CA2078871C Cyclopropyl squalene derivatives and their use as inhibitors of cholesterol synthesis |
| 06/26/2001 | CA1341266C Combination of pyrimidine derivatives and antibacterial agents to induce and stimulate hair growth and reduce hair loss |
| 06/26/2001 | CA1341265C Combination based on pyrimidine derivatives and calcium antagonists to induce and stimulate hair growth and reduce hair loss |
| 06/26/2001 | CA1341264C Combination of 1,8-hydroxy and/or acyloxy anthracene or anthrone derivatives and pyrimidine derivatives to induce and stimulate hair growth and reduce hair loss |
| 06/26/2001 | CA1341261C Process for the synthesis of 3',4'-anhydrovinblastine, vinblastine and vincristine |
| 06/24/2001 | CA2329516A1 Tetrahydroisoquinoline compounds as estrogen agonists/antagonists |
| 06/22/2001 | CA2329678A1 Ep4 receptor selective agonists in the treatment of osteoporosis |
| 06/22/2001 | CA2329296A1 Method for immobilizing allergens |
| 06/21/2001 | WO2001045693A1 Use of carboxy compounds such as 2(4-acetoxyphenyl)-2-chloro-n-methyl-ethylammonium chloride as anti-inflammatory agents |
| 06/21/2001 | WO2001044489A2 Galactomannan oligosaccharides and methods for the production and use thereof |
| 06/21/2001 | WO2001044488A1 Novel substance originating in basidiomycete culture, process for producing the same and use thereof |
| 06/21/2001 | WO2001044485A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation |
| 06/21/2001 | WO2001044473A2 Polypeptides and nucleic acids encoding same |
| 06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
| 06/21/2001 | WO2001044465A2 Therapeutically useful synthetic oligonucleotides |
| 06/21/2001 | WO2001044455A2 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 06/21/2001 | WO2001044445A2 Human lyases and associated proteins |
| 06/21/2001 | WO2001044295A2 Agonists and antagonists of the receptor gpr19 and their use in appetite control |
| 06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
| 06/21/2001 | WO2001044271A2 Daptomycin analogs and their use as antibacterial agents |
| 06/21/2001 | WO2001044268A1 Halogenated sulphamate-, phosphonate-, thiophosphonate-, sulphonate- and sulphonamide- compounds as inhibitors of steroid sulphatase |
| 06/21/2001 | WO2001044267A1 11-β-PHENYLESTRADIENE DERIVATIVES WITH FLUOROALKYL GROUPS IN THE AROMATIC SIDE CHAIN, PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS |
| 06/21/2001 | WO2001044265A1 Treatment of mental conditions including depression |
| 06/21/2001 | WO2001044264A2 Novel stromelysin inhibitors |
| 06/21/2001 | WO2001044262A1 Processes for preparing clarithromycin polymorphs and novel polymorph iv |
| 06/21/2001 | WO2001044260A2 Novel purines |
| 06/21/2001 | WO2001044259A1 Purine derivatives |
| 06/21/2001 | WO2001044258A1 Novel heterocycles |
| 06/21/2001 | WO2001044254A1 Cyclopenteneone derivatives |
| 06/21/2001 | WO2001044250A1 SUBSTITUTED 1,2,3-TRIAZOLO[1,5-a]QUINAZOLINES FOR ENHANCING COGNITION |
| 06/21/2001 | WO2001044249A1 Triazolo-pyrimidine derivatives as ligands for gaba receptors |
| 06/21/2001 | WO2001044248A1 Imidazopyrimidinyl and imidazopyridinyl derivatives |
| 06/21/2001 | WO2001044246A1 Bicyclic inhibitors of glycogen synthase kinase 3 |
| 06/21/2001 | WO2001044245A1 Saccharin derivatives as orally active elastase inhibitors |
| 06/21/2001 | WO2001044244A1 Pyrazolo-pyridine derivatives as ligands for gaba receptors |
| 06/21/2001 | WO2001044243A2 Novel heteroaryl-diazabicycloalkanes |
| 06/21/2001 | WO2001044242A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044241A1 N-[5-[[[5-alkyl-2-oxazolyl]methyl]thio]-2-thiazolyl]-carboxamide inhibitors of cyclin dependent kinases |
| 06/21/2001 | WO2001044240A1 Antidiabetic thiazolidinediones and their preparation |
| 06/21/2001 | WO2001044239A2 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
| 06/21/2001 | WO2001044238A1 Pyrazolyl benzyl ethers |
| 06/21/2001 | WO2001044237A1 Thienylalanine derivatives as inhibitors of cell adhesion |
| 06/21/2001 | WO2001044234A1 Substituted bisindolylmaleimides for the inhibition of cell proliferation |